Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • Video Articles
    • AJNR Case Collection
    • Case of the Week Archive
    • Case of the Month Archive
    • Classic Case Archive
  • Special Collections
    • Advancing NeuroMRI with High-Relaxivity Contrast Agents
    • AJNR Awards
    • Low-Field MRI
    • Alzheimer Disease
    • ASNR Foundation Special Collection
    • Photon-Counting CT
    • View All
  • Multimedia
    • AJNR Podcasts
    • AJNR SCANtastic
    • Trainee Corner
    • MRI Safety Corner
    • Imaging Protocols
  • For Authors
    • Submit a Manuscript
    • Submit a Video Article
    • Submit an eLetter to the Editor/Response
    • Manuscript Submission Guidelines
    • Statistical Tips
    • Fast Publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Imaging Protocol Submission
    • Author Policies
  • About Us
    • About AJNR
    • Editorial Board
    • Editorial Board Alumni
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

AJNR Awards, New Junior Editors, and more. Read the latest AJNR updates


Improved Turnaround Times | Median time to first decision: 12 days

Review ArticleReview Articles
Open Access

Addictive Illegal Drugs: Structural Neuroimaging

S. Geibprasert, M. Gallucci and T. Krings
American Journal of Neuroradiology May 2010, 31 (5) 803-808; DOI: https://doi.org/10.3174/ajnr.A1811
S. Geibprasert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Gallucci
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T. Krings
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

References

  1. 1.↵
    1. Fowler JS,
    2. Volkow ND,
    3. Kassed CA,
    4. et al
    . Imaging the addicted human brain. Sci Pract Perspect 2007;3:4–16
    PubMed
  2. 2.↵
    1. Gatley SJ,
    2. Volkow ND
    . Addiction and imaging of the living human brain. Drug Alcohol Depend 1998;51:97–108
    CrossRefPubMedWeb of Science
  3. 3.↵
    1. Lingford-Hughes AR,
    2. Davies SJ,
    3. McIver S,
    4. et al
    . Addiction. Br Med Bull 2003;65:209–22
    Abstract/FREE Full Text
  4. 4.↵
    1. Magalhaes AC
    . Functional magnetic resonance and spectroscopy in drug and substance abuse. Top Magn Reson Imaging 2005;16:247–51
    CrossRefPubMed
  5. 5.↵
    1. Mena JC,
    2. Cuellar H,
    3. Vargas D,
    4. et al
    . PET and SPECT in drug and substance abuse. Top Magn Reson Imaging 2005;16:253–56
    CrossRefPubMed
  6. 6.↵
    1. Moussouttas M
    . Cannabis use and cerebrovascular disease. Neurologist 2004;10:47–53
    CrossRefPubMedWeb of Science
  7. 7.↵
    1. Chang L,
    2. Chronicle EP
    . Functional imaging studies in cannabis users. Neuroscientist 2007;13:422–32
    Abstract/FREE Full Text
  8. 8.↵
    1. Quickfall J,
    2. Crockford D
    . Brain neuroimaging in cannabis use: a review. J Neuropsychiatry Clin Neurosci 2006;18:318–32
    CrossRefPubMedWeb of Science
  9. 9.↵
    1. Iversen L
    . Cannabis and the brain. Brain 2003;126:1252–70
    Abstract/FREE Full Text
  10. 10.↵
    1. Mateo I,
    2. Pinedo A,
    3. Gomez-Beldarrain M,
    4. et al
    . Recurrent stroke associated with cannabis use. J Neurol Neurosurg Psychiatry 2005;76:435–37
    Abstract/FREE Full Text
  11. 11.↵
    1. Mathew RJ,
    2. Wilson WH,
    3. Humphreys DF,
    4. et al
    . Regional cerebral blood flow after marijuana smoking. J Cereb Blood Flow Metab 1992;12:750–58
    PubMedWeb of Science
  12. 12.↵
    1. O'Leary DS,
    2. Block RI,
    3. Koeppel JA,
    4. et al
    . Effects of smoking marijuana on brain perfusion and cognition. Neuropsychopharmacology 2002;26:802–16
    CrossRefPubMedWeb of Science
  13. 13.↵
    1. Herning RI,
    2. Better WE,
    3. Tate K,
    4. et al
    . Marijuana abusers are at increased risk for stroke: preliminary evidence from cerebrovascular perfusion data. Ann N Y Acad Sci 2001;939:413–15
    PubMedWeb of Science
  14. 14.↵
    1. Aydin K,
    2. Sencer S,
    3. Ogel K,
    4. et al
    . Single-voxel proton MR spectroscopy in toluene abuse. Magn Reson Imaging 2003;21:777–85
    CrossRefPubMedWeb of Science
  15. 15.↵
    1. Yamanouchi N,
    2. Okada S,
    3. Kodama K,
    4. et al
    . White matter changes caused by chronic solvent abuse. AJNR Am J Neuroradiol 1995;16:1643–49
    Abstract
  16. 16.↵
    1. Aydin K,
    2. Sencer S,
    3. Demir T,
    4. et al
    . Cranial MR findings in chronic toluene abuse by inhalation. AJNR Am J Neuroradiol 2002;23:1173–79
    Abstract/FREE Full Text
  17. 17.↵
    1. King MD
    . Neurological sequelae of toluene abuse. Hum Toxicol 1982;1:281–87
    PubMedWeb of Science
  18. 18.↵
    1. Lazar RB,
    2. Ho SU,
    3. Melen O,
    4. et al
    . Multifocal central nervous system damage caused by toluene abuse. Neurology 1983;33:1337–40
    Abstract/FREE Full Text
  19. 19.↵
    1. Unger E,
    2. Alexander A,
    3. Fritz T,
    4. et al
    . Toluene abuse: physical basis for hypointensity of the basal ganglia on T2-weighted MR images. Radiology 1994;193:473–76
    PubMed
  20. 20.↵
    1. Kamran S,
    2. Bakshi R
    . MRI in chronic toluene abuse: low signal in the cerebral cortex on T2-weighted images. Neuroradiology 1998;40:519–21
    CrossRefPubMedWeb of Science
  21. 21.↵
    1. Williams MJ,
    2. Adinoff B
    . The role of acetylcholine in cocaine addiction. Neuropsychopharmacology 2008;33:1779–97
    CrossRefPubMedWeb of Science
  22. 22.↵
    1. Brown E,
    2. Prager J,
    3. Lee HY,
    4. et al
    . CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. AJR Am J Roentgenol 1992;159:137–47
    PubMedWeb of Science
  23. 23.↵
    1. Nolte KB,
    2. Gelman BB
    . Intracerebral hemorrhage associated with cocaine abuse. Arch Pathol Lab Med 1989;113:812–13
    PubMedWeb of Science
  24. 24.↵
    1. McEvoy AW,
    2. Kitchen ND,
    3. Thomas DG
    . Intracerebral haemorrhage and drug abuse in young adults. Br J Neurosurg 2000;14:449–54
    CrossRefPubMed
  25. 25.↵
    1. Pozzi M,
    2. Roccatagliata D,
    3. Sterzi R
    . Drug abuse and intracranial hemorrhage. Neurol Sci 2008;29(suppl 2):S269–270
    PubMedWeb of Science
  26. 26.↵
    1. Levine SR,
    2. Brust JC,
    3. Futrell N,
    4. et al
    . Cerebrovascular complications of the use of the “crack” form of alkaloidal cocaine. N Engl J Med 1990;323:699–704
    CrossRefPubMedWeb of Science
  27. 27.↵
    1. Krendel DA,
    2. Ditter SM,
    3. Frankel MR,
    4. et al
    . Biopsy-proven cerebral vasculitis associated with cocaine abuse. Neurology 1990;40:1092–94
    Abstract/FREE Full Text
  28. 28.↵
    1. Nolte KB,
    2. Brass LM,
    3. Fletterick CF
    . Intracranial hemorrhage associated with cocaine abuse: a prospective autopsy study. Neurology 1996;46:1291–96
    Abstract/FREE Full Text
  29. 29.↵
    1. Kaufman MJ,
    2. Levin JM,
    3. Ross MH,
    4. et al
    . Cocaine-induced cerebral vasoconstriction detected in humans with magnetic resonance angiography. JAMA 1998;279:376–80
    CrossRefPubMedWeb of Science
  30. 30.↵
    1. Rojas R,
    2. Riascos R,
    3. Vargas D,
    4. et al
    . Neuroimaging in drug and substance abuse. Part I. Cocaine, cannabis, and ecstasy. Top Magn Reson Imaging 2005;16:231–38
    CrossRefPubMed
  31. 31.↵
    1. Hurley RA,
    2. Reneman L,
    3. Taber KH
    . Ecstasy in the brain: a model for neuroimaging. J Neuropsychiatry Clin Neurosci 2002;14:125–29
    CrossRefPubMed
  32. 32.↵
    1. Morgan MJ
    . Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology (Berl) 2000;152:230–48
    CrossRefPubMed
  33. 33.↵
    1. Green AR,
    2. Mechan AO,
    3. Elliott JM,
    4. et al
    . The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”). Pharmacol Rev 2003;55:463–508
    Abstract/FREE Full Text
  34. 34.↵
    1. Reneman L,
    2. Habraken JB,
    3. Majoie CB,
    4. et al
    . MDMA (“Ecstasy”) and its association with cerebrovascular accidents: preliminary findings. AJNR Am J Neuroradiol 2000;21:1001–07
    Abstract/FREE Full Text
  35. 35.↵
    1. Henry JA,
    2. Jeffreys KJ,
    3. Dawling S
    . Toxicity and deaths from 3,4-methylenedioxymethamphetamine (“ecstasy”). Lancet 1992;340:384–87
    CrossRefPubMedWeb of Science
  36. 36.↵
    1. Spatt J,
    2. Glawar B,
    3. Mamoli B
    . A pure amnestic syndrome after MDMA (“ecstasy”) ingestion. J Neurol Neurosurg Psychiatry 1997;62:418–19
    FREE Full Text
  37. 37.↵
    1. Squier MV,
    2. Jalloh S,
    3. Hilton-Jones D,
    4. et al
    . Death after ecstasy ingestion: neuropathological findings. J Neurol Neurosurg Psychiatry 1995;58:756
    FREE Full Text
  38. 38.↵
    1. Bae SC,
    2. Lyoo IK,
    3. Sung YH,
    4. et al
    . Increased white matter hyperintensities in male methamphetamine abusers. Drug Alcohol Depend 2006;81:83–88
    CrossRefPubMedWeb of Science
  39. 39.↵
    1. Borne J,
    2. Riascos R,
    3. Cuellar H,
    4. et al
    . Neuroimaging in drug and substance abuse. Part II. Opioids and solvents. Top Magn Reson Imaging 2005;16:239–45
    CrossRefPubMed
  40. 40.↵
    1. Trescot AM,
    2. Datta S,
    3. Lee M,
    4. et al
    . Opioid pharmacology. Pain Physician 2008;11(2 suppl):S133–153
    PubMedWeb of Science
  41. 41.↵
    1. Buttner A,
    2. Mall G,
    3. Penning R,
    4. et al
    . The neuropathology of heroin abuse. Forensic Sci Int 2000;113:435–42
    CrossRefPubMedWeb of Science
  42. 42.↵
    1. Brust JC,
    2. Richter RW
    . Stroke associated with addiction to heroin. J Neurol Neurosurg Psychiatry 1976;39:194–99
    Abstract/FREE Full Text
  43. 43.↵
    1. Volkow ND,
    2. Valentine A,
    3. Kulkarni M
    . Radiological and neurological changes in the drug abuse patient: a study with MRI. J Neuroradiol 1988;15:288–93
    PubMedWeb of Science
  44. 44.↵
    1. Andersen SN,
    2. Skullerud K
    . Hypoxic/ischaemic brain damage, especially pallidal lesions, in heroin addicts. Forensic Sci Int 1999;102:51–59
    CrossRefPubMedWeb of Science
  45. 45.↵
    1. Bartlett E,
    2. Mikulis DJ
    . Chasing “chasing the dragon” with MRI: leukoencephalopathy in drug abuse. Br J Radiol 2005;78:997–1004
    Abstract/FREE Full Text
  46. 46.↵
    1. Keogh CF,
    2. Andrews GT,
    3. Spacey SD,
    4. et al
    . Neuroimaging features of heroin inhalation toxicity: “chasing the dragon. ” AJR Am J Roentgenol 2003;180:847–50
    PubMedWeb of Science
  47. 47.↵
    1. Offiah C,
    2. Hall E
    . Heroin-induced leukoencephalopathy: characterization using MRI, diffusion-weighted imaging, and MR spectroscopy. Clin Radiol 2008;63:146–52
    CrossRefPubMedWeb of Science
  48. 48.↵
    1. Schiffer D,
    2. Brignolio F,
    3. Giordana MT,
    4. et al
    . Spongiform encephalopathy in addicts inhaling pre-heated heroin. Clin Neuropathol 1985;4:174–80
    PubMedWeb of Science
  49. 49.↵
    1. Wolters EC,
    2. van Wijngaarden GK,
    3. Stam FC,
    4. et al
    . Leucoencephalopathy after inhaling “heroin” pyrolysate. Lancet 1982;2:1233–37
    PubMedWeb of Science
  50. 50.↵
    1. Pruitt AA,
    2. Rubin RH,
    3. Karchmer AW,
    4. et al
    . Neurologic complications of bacterial endocarditis. Medicine (Baltimore) 1978;57:329–43
    PubMedWeb of Science
  51. 51.↵
    1. Ramsey RG,
    2. Gunnar RM,
    3. Tobin JR Jr.
    . Endocarditis in the drug addict. Am J Cardiol 1970;25:608–18
    CrossRefPubMedWeb of Science
  52. 52.↵
    1. Tunkel AR,
    2. Pradhan SK
    . Central nervous system infections in injection drug users. Infect Dis Clin North Am 2002;16:589–605
    CrossRefPubMed
  53. 53.↵
    1. Falcone S,
    2. Post MJ
    . Encephalitis, cerebritis, and brain abscess: pathophysiology and imaging findings. Neuroimaging Clin N Am 2000;10:333–53
    PubMed
  54. 54.↵
    1. Leuthardt EC,
    2. Wippold FJ 2nd.,
    3. Oswood MC,
    4. et al
    . Diffusion-weighted MR imaging in the preoperative assessment of brain abscesses. Surg Neurol 2002;58:395–402,discussion 402
    CrossRefPubMedWeb of Science
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 31 (5)
American Journal of Neuroradiology
Vol. 31, Issue 5
1 May 2010
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Addictive Illegal Drugs: Structural Neuroimaging
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
S. Geibprasert, M. Gallucci, T. Krings
Addictive Illegal Drugs: Structural Neuroimaging
American Journal of Neuroradiology May 2010, 31 (5) 803-808; DOI: 10.3174/ajnr.A1811

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Addictive Illegal Drugs: Structural Neuroimaging
S. Geibprasert, M. Gallucci, T. Krings
American Journal of Neuroradiology May 2010, 31 (5) 803-808; DOI: 10.3174/ajnr.A1811
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Abbreviations
    • Cannabis
    • Organic Solvents: Inhalants (Toluene)
    • Amphetamines and Derivatives
    • Opioids and Derivatives
    • Conclusions
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • MicroRNA-mRNA networks are dysregulated in opioid use disorder postmortem brain: further evidence for opioid-induced neurovascular alterations
  • Cannabis-related Stroke: Myth or Reality?
  • Crossref
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

More in this TOC Section

  • An Atlas of Neonatal Neurovascular Imaging Anatomy as Depicted with Microvascular Imaging: The Intracranial Arteries
  • An Atlas of Neonatal Neurovascular Imaging Anatomy as Depicted with Microvascular Imaging: The Intracranial Veins
  • Clinical Translation of Hyperpolarized 13C Metabolic Probes for Glioma Imaging
Show more Review Articles

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editor's Choice
  • Fellows' Journal Club
  • Letters to the Editor
  • Video Articles

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

More from AJNR

  • Trainee Corner
  • Imaging Protocols
  • MRI Safety Corner
  • Book Reviews

Multimedia

  • AJNR Podcasts
  • AJNR Scantastics

Resources

  • Turnaround Time
  • Submit a Manuscript
  • Submit a Video Article
  • Submit an eLetter to the Editor/Response
  • Manuscript Submission Guidelines
  • Statistical Tips
  • Fast Publishing of Accepted Manuscripts
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Author Policies
  • Become a Reviewer/Academy of Reviewers
  • News and Updates

About Us

  • About AJNR
  • Editorial Board
  • Editorial Board Alumni
  • Alerts
  • Permissions
  • Not an AJNR Subscriber? Join Now
  • Advertise with Us
  • Librarian Resources
  • Feedback
  • Terms and Conditions
  • AJNR Editorial Board Alumni

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire